Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

ALKS vs INTR

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.89B
5Y Perf.+18.6%
INTR
Inter & Co, Inc.

Banks - Regional

Financial ServicesNASDAQ • BR
Market Cap$2.54B
5Y Perf.+273.3%

ALKS vs INTR — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ALKS logoALKS
INTR logoINTR
IndustryBiotechnologyBanks - Regional
Market Cap$5.89B$2.54B
Revenue (TTM)$1.56B$9.71B
Net Income (TTM)$153M$1.21B
Gross Margin65.4%47.4%
Operating Margin12.3%12.4%
Forward P/E24.7x1.9x
Total Debt$70M$11.86B
Cash & Equiv.$1.12B$6.84B

ALKS vs INTRLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ALKS
INTR
StockJun 22May 26Return
Alkermes plc (ALKS)100118.6+18.6%
Inter & Co, Inc. (INTR)100373.3+273.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: ALKS vs INTR

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: INTR leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Alkermes plc is the stronger pick specifically for profitability and margin quality and capital preservation and lower volatility. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
ALKS
Alkermes plc
The Income Pick

ALKS is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • Dividend streak 0 yrs, beta 1.06
  • Lower volatility, beta 1.06, Low D/E 3.8%, current ratio 3.55x
  • Beta 1.06, current ratio 3.55x
Best for: income & stability and sleep-well-at-night
INTR
Inter & Co, Inc.
The Banking Pick

INTR carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 27.1%, EPS growth 176.0%
  • 131.7% 10Y total return vs ALKS's -7.7%
  • 27.1% NII/revenue growth vs ALKS's -5.2%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthINTR logoINTR27.1% NII/revenue growth vs ALKS's -5.2%
ValueINTR logoINTRLower P/E (1.9x vs 24.7x)
Quality / MarginsALKS logoALKS9.8% margin vs INTR's 9.3%
Stability / SafetyALKS logoALKSBeta 1.06 vs INTR's 1.39, lower leverage
DividendsINTR logoINTR0.4% yield; 2-year raise streak; the other pay no meaningful dividend
Momentum (1Y)INTR logoINTR+18.2% vs ALKS's +16.3%
Efficiency (ROA)ALKS logoALKS5.4% ROA vs INTR's 1.3%, ROIC 18.9% vs 4.8%

ALKS vs INTR — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
INTRInter & Co, Inc.

Segment breakdown not available.

ALKS vs INTR — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLINTRLAGGINGALKS

Income & Cash Flow (Last 12 Months)

INTR leads this category, winning 3 of 5 comparable metrics.

INTR is the larger business by revenue, generating $9.7B annually — 6.2x ALKS's $1.6B. Profitability is closely matched — net margins range from 9.8% (ALKS) to 9.3% (INTR).

MetricALKS logoALKSAlkermes plcINTR logoINTRInter & Co, Inc.
RevenueTrailing 12 months$1.6B$9.7B
EBITDAEarnings before interest/tax$212M$1.8B
Net IncomeAfter-tax profit$153M$1.2B
Free Cash FlowCash after capex$392M$4.9B
Gross MarginGross profit ÷ Revenue+65.4%+47.4%
Operating MarginEBIT ÷ Revenue+12.3%+12.4%
Net MarginNet income ÷ Revenue+9.8%+9.3%
FCF MarginFCF ÷ Revenue+25.1%+33.5%
Rev. Growth (YoY)Latest quarter vs prior year+28.2%
EPS Growth (YoY)Latest quarter vs prior year-4.1%+38.9%
INTR leads this category, winning 3 of 5 comparable metrics.

Valuation Metrics

INTR leads this category, winning 5 of 5 comparable metrics.

At 18.7x trailing earnings, INTR trades at a 24% valuation discount to ALKS's 24.7x P/E. On an enterprise value basis, INTR's 12.4x EV/EBITDA is more attractive than ALKS's 17.2x.

MetricALKS logoALKSAlkermes plcINTR logoINTRInter & Co, Inc.
Market CapShares × price$5.9B$2.5B
Enterprise ValueMkt cap + debt − cash$4.8B$3.6B
Trailing P/EPrice ÷ TTM EPS24.70x18.70x
Forward P/EPrice ÷ next-FY EPS est.1.88x
PEG RatioP/E ÷ EPS growth rate0.15x
EV / EBITDAEnterprise value multiple17.20x12.42x
Price / SalesMarket cap ÷ Revenue3.99x1.29x
Price / BookPrice ÷ Book value/share3.28x1.87x
Price / FCFMarket cap ÷ FCF12.25x3.86x
INTR leads this category, winning 5 of 5 comparable metrics.

Profitability & Efficiency

ALKS leads this category, winning 7 of 8 comparable metrics.

INTR delivers a 12.4% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $9 for ALKS. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to INTR's 1.31x.

MetricALKS logoALKSAlkermes plcINTR logoINTRInter & Co, Inc.
ROE (TTM)Return on equity+8.8%+12.4%
ROA (TTM)Return on assets+5.4%+1.3%
ROICReturn on invested capital+18.9%+4.8%
ROCEReturn on capital employed+14.2%+6.0%
Piotroski ScoreFundamental quality 0–977
Debt / EquityFinancial leverage0.04x1.31x
Net DebtTotal debt minus cash-$1.0B$5.0B
Cash & Equiv.Liquid assets$1.1B$6.8B
Total DebtShort + long-term debt$70M$11.9B
Interest CoverageEBIT ÷ Interest expense32.30x0.29x
ALKS leads this category, winning 7 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

INTR leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in INTR five years ago would be worth $23,170 today (with dividends reinvested), compared to $16,047 for ALKS. Over the past 12 months, INTR leads with a +18.2% total return vs ALKS's +16.3%. The 3-year compound annual growth rate (CAGR) favors INTR at 62.5% vs ALKS's 4.5% — a key indicator of consistent wealth creation.

MetricALKS logoALKSAlkermes plcINTR logoINTRInter & Co, Inc.
YTD ReturnYear-to-date+25.0%-5.9%
1-Year ReturnPast 12 months+16.3%+18.2%
3-Year ReturnCumulative with dividends+14.3%+328.9%
5-Year ReturnCumulative with dividends+60.5%+131.7%
10-Year ReturnCumulative with dividends-7.7%+131.7%
CAGR (3Y)Annualised 3-year return+4.5%+62.5%
INTR leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

ALKS leads this category, winning 2 of 2 comparable metrics.

ALKS is the less volatile stock with a 1.06 beta — it tends to amplify market swings less than INTR's 1.39 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 96.5% from its 52-week high vs INTR's 75.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricALKS logoALKSAlkermes plcINTR logoINTRInter & Co, Inc.
Beta (5Y)Sensitivity to S&P 5001.06x1.39x
52-Week HighHighest price in past year$36.60$10.36
52-Week LowLowest price in past year$25.17$6.40
% of 52W HighCurrent price vs 52-week peak+96.5%+75.7%
RSI (14)Momentum oscillator 0–10066.642.1
Avg Volume (50D)Average daily shares traded2.3M3.0M
ALKS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

INTR leads this category, winning 1 of 1 comparable metric.

Wall Street rates ALKS as "Buy" and INTR as "Buy". Consensus price targets imply 53.1% upside for INTR (target: $12) vs 24.6% for ALKS (target: $44). INTR is the only dividend payer here at 0.40% yield — a key consideration for income-focused portfolios.

MetricALKS logoALKSAlkermes plcINTR logoINTRInter & Co, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$44.00$12.00
# AnalystsCovering analysts286
Dividend YieldAnnual dividend ÷ price+0.4%
Dividend StreakConsecutive years of raises02
Dividend / ShareAnnual DPS$0.16
Buyback YieldShare repurchases ÷ mkt cap+0.5%+0.2%
INTR leads this category, winning 1 of 1 comparable metric.
Key Takeaway

INTR leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). ALKS leads in 2 (Profitability & Efficiency, Risk & Volatility).

Best OverallInter & Co, Inc. (INTR)Leads 4 of 6 categories
Loading custom metrics...

ALKS vs INTR: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is ALKS or INTR a better buy right now?

For growth investors, Inter & Co, Inc.

(INTR) is the stronger pick with 27. 1% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). Inter & Co, Inc. (INTR) offers the better valuation at 18. 7x trailing P/E (1. 9x forward), making it the more compelling value choice. Analysts rate Alkermes plc (ALKS) a "Buy" — based on 28 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ALKS or INTR?

On trailing P/E, Inter & Co, Inc.

(INTR) is the cheapest at 18. 7x versus Alkermes plc at 24. 7x.

03

Which is the better long-term investment — ALKS or INTR?

Over the past 5 years, Inter & Co, Inc.

(INTR) delivered a total return of +131. 7%, compared to +60. 5% for Alkermes plc (ALKS). Over 10 years, the gap is even starker: INTR returned +131. 7% versus ALKS's -7. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ALKS or INTR?

By beta (market sensitivity over 5 years), Alkermes plc (ALKS) is the lower-risk stock at 1.

06β versus Inter & Co, Inc. 's 1. 39β — meaning INTR is approximately 32% more volatile than ALKS relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 131% for Inter & Co, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — ALKS or INTR?

By revenue growth (latest reported year), Inter & Co, Inc.

(INTR) is pulling ahead at 27. 1% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: Inter & Co, Inc. grew EPS 176. 0% year-over-year, compared to -34. 1% for Alkermes plc. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ALKS or INTR?

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus 9. 3% for Inter & Co, Inc. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus 12. 4% for INTR. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ALKS or INTR more undervalued right now?

Analyst consensus price targets imply the most upside for INTR: 53.

1% to $12. 00.

08

Which pays a better dividend — ALKS or INTR?

In this comparison, INTR (0.

4% yield) pays a dividend. ALKS does not pay a meaningful dividend and should not be held primarily for income.

09

Is ALKS or INTR better for a retirement portfolio?

For long-horizon retirement investors, Alkermes plc (ALKS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

06)). Both have compounded well over 10 years (ALKS: -7. 7%, INTR: +131. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ALKS and INTR?

These companies operate in different sectors (ALKS (Healthcare) and INTR (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ALKS is a small-cap quality compounder stock; INTR is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

INTR

High-Growth Disruptor

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 13%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ALKS and INTR on the metrics below

Revenue Growth>
%
(ALKS: 28.2% · INTR: 27.1%)
Net Margin>
%
(ALKS: 9.8% · INTR: 9.3%)
P/E Ratio<
x
(ALKS: 24.7x · INTR: 18.7x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.